We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Medical News and Perspectives |

FDA Warning: Driving May Be Impaired the Morning Following Sleeping Pill Use

Bridget M. Kuehn, MSJ
JAMA. 2013;309(7):645-646. doi:10.1001/jama.2013.323.
Text Size: A A A
Published online


Even after a night of sleep, individuals who have taken sleeping pills may remain too impaired to drive or execute other tasks that require alertness, according to the latest US Food and Drug Administration (FDA) safety notice about medications designed to help patients sleep.

The warning (http://tinyurl.com/b7kc4r2) focuses on the popular sleep medication zolpidem, which data reviewed by the FDA suggest may persist at levels high enough to impair driving 8 hours or more after dosing. To mitigate such risk, the FDA is recommending physicians prescribe the lowest dose necessary and is requiring manufacturers of the drugs to lower the recommended doses that appear on the drug's label. Women and individuals who have taken extended-release formulations of zolpidem may be at particularly increased risk of impaired alertness the morning after taking these medications, noted the agency.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Sleep medications, particularly zolpidem, may decrease a patient's alertness the next day enough to impair driving, according to the US Food and Drug Administration.

(Photo credit: Chris Gallagher/www.sciencesource.com)



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

10 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles